Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycosidic linkages in mucin oligosaccharide chains are the covalent bonds that anchor complex O-glycans to the protein core of mucins, primarily through N-acetylgalactosamine (GalNAc) attached to serine or threonine residues [1]. These linkages are fundamental to the structural integrity and physicochemical properties of mucus, which serves as a critical protective barrier for epithelial surfaces in the respiratory, gastrointestinal, and urogenital tracts [1]. Biologically, the dense clusters of these O-glycans create a 'bottle-brush' conformation that allows mucins to retain water and provide lubrication. In various diseases, particularly epithelial cancers, these linkages are altered by the dysregulation of glycosyltransferases, resulting in truncated glycan structures like the Tn and Sialyl-Tn antigens [3]. These aberrant structures facilitate tumor progression, immune evasion, and metastasis by altering cell-cell interactions and signaling. While most clinical mucolytics target disulfide bridges, agents such as bromhexine and ambroxol are described as acting on these glycosidic structures by stimulating lysosomal activity to depolymerize mucopolysaccharide fibers [2]. Consequently, these linkages represent a focal point for understanding mucus rheology and developing targeted glycan-based therapies or diagnostics in oncology and chronic inflammatory airway diseases [3].
Depolymerization of mucopolysaccharide fibers through the stimulation of lysosomal enzymes that hydrolyze glycosidic bonds.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucin-type O-glycan glycosidic linkage.